心血管代谢疾病数量与认知能力的关联:47万英国生物银行参与者分析
基于英国生物银行474129名参与者的基线数据,分析高血压、冠心病和糖尿病与推理、信息处理速度和记忆认知评分的关联。三种疾病均与较差认知评分相关,且疾病数量呈现相加的损害剂量效应。作者认为预防或延迟心血管病或糖尿病可能延迟认知衰退。
要点
- 高血压、冠心病和糖尿病均与推理、信息处理速度和记忆测试评分较差相关。
- 心血管代谢疾病数量对推理评分呈相加剂量效应,每增加一种疾病β=-0.052分(满分13分),95%CI -0.063至-0.041,P<0.001。
- 反应时指数化β=1.005(即慢0.5%),95%CI 1.004-1.005,P<0.001;记忆错误指数化β=1.005(即多0.5%错误),95%CI 1.003-1.008。
核心结论
- 心血管代谢疾病与较差的认知能力相关,且疾病数量增加的潜在效应似乎呈相加性,预防或延迟心血管病或糖尿病可能延迟认知衰退和可能的痴呆。
研究设计与样本
- 基于英国生物银行基线队列评估的横断面分析,纳入474129名具有相关数据的参与者,认知测试涵盖推理、信息处理速度和记忆领域,并调整多种潜在混杂变量。
主要发现
- 与报告无高血压、冠心病和糖尿病的对照组相比,高血压、冠心病和糖尿病的存在通常与所有测试的较差认知评分相关。
- 推理评分中,每增加一种心血管代谢疾病的未标准化相加剂量β=-0.052分(满分13分),95%CI -0.063至-0.041,P<0.001。
- 对数反应时评分的指数化β=1.005(即慢0.5%),95%CI 1.004-1.005,P<0.001。
- 对数记忆错误评分的指数化β=1.005(即多0.5%错误),95%CI 1.003-1.008。
关键数值与推荐
- 推理评分每增加一种疾病未标准化相加剂量β=-0.052分(满分13分),95%CI -0.063至-0.041,P<0.001。
- 对数反应时指数化β=1.005(慢0.5%),95%CI 1.004-1.005,P<0.001。
- 对数记忆错误指数化β=1.005(多0.5%错误),95%CI 1.003-1.008。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Cardiometabolic diseases (hypertension, coronary artery disease [CAD] and diabetes are known to associate with poorer cognitive ability but there are limited data on whether having more than one of these conditions is associated with additive effects. We aimed to quantify the magnitude of their associations with non-demented cognitive abilities and determine the extent to which these associations were additive. METHODS AND RESULTS: We examined cognitive test scores in domains of reasoning, information processing speed and memory, included as part of the baseline UK Biobank cohort assessment (N = 474 129 with relevant data), adjusting for a range of potentially confounding variables. The presence of hypertension, CAD and diabetes generally associated with poorer cognitive scores on all tests, compared with a control group that reported none of these diseases. There was evidence of an additive deleterious dose effect of an increasing number of cardiometabolic diseases, for reasoning scores (unstandardized additive dose beta per disease = -0.052 score points out of 13, 95% CI [confidence intervals] -0.063 to - 0.041, P < 0.001), log reaction time scores (exponentiated beta = 1.005, i.e. 0.5% slower, 95% CI 1.004-1.005, P < 0.001) and log memory errors (exponentiated beta = 1.005 i.e. 0.5% more errors; 95% CI 1.003-1.008). CONCLUSION: Cardiometabolic diseases are associated with worse cognitive abilities, and the potential effect of an increasing number of cardiometabolic conditions appears additive. These results reinforce the notion that preventing or delaying cardiovascular disease or diabetes may delay cognitive decline and possible dementia.
引用
- Lyall DM, Celis-Morales CA, Anderson J, et al. Associations between single and multiple cardiometabolic diseases and cognitive abilities in 474 129 UK Biobank participants. Eur Heart J. 2017. PMID: 28363219. doi:10.1093/eurheartj/ehw528
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。